| Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience. | |
| | |
MedLine Citation:
|
PMID: 12582408 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A total of 26 postmarketing cases of allergic contact dermatitis to doxepin 5% cream were reported to the Food and Drug Administration. Our findings suggest that allergic contact dermatitis was more common when treatment duration exceeded the recommended 8 days. Allergic contact dermatitis to doxepin cream should be considered in patients whose condition fails to improve or worsens with doxepin use. |
| | |
Authors:
|
Renan A Bonnel; Lois La Grenade; Claudia B Karwoski; Julie G Beitz |
Related Documents
:
|
18086998 - A 3-year causative study of pompholyx in 120 patients. 20161868 - Low chromate diet in dermatology. 2882598 - Circulating tachykinins (substance p, neurokinin a, neuropeptide k) and the carcinoid f... 3411388 - Atopic dermatitis: clinical relevance of food hypersensitivity reactions. 15668678 - Dietary fiber intake by american preschoolers is associated with more nutrient-dense di... 11830278 - Chronic intraparaventricular nuclear administration of orexin a in male rats does not a... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of the American Academy of Dermatology Volume: 48 ISSN: 0190-9622 ISO Abbreviation: J. Am. Acad. Dermatol. Publication Date: 2003 Feb |
Date Detail:
|
Created Date: 2003-02-12 Completed Date: 2003-03-07 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7907132 Medline TA: J Am Acad Dermatol Country: United States |
Other Details:
|
Languages: eng Pagination: 294-6 Citation Subset: IM |
Affiliation:
|
Center for Drug Evaluation and Research, Food and Drug Administration, 5600 Fishers Lane, Room 15B-23, HFD-430, Rockville, MD 20857, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Topical Adult Antipruritics / administration & dosage, adverse effects* Dermatitis, Allergic Contact / etiology* Doxepin / administration & dosage, adverse effects* Female Humans Male Middle Aged Product Surveillance, Postmarketing* |
| Chemical | |
Reg. No./Substance:
|
0/Antipruritics; 1668-19-5/Doxepin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Rickettsialpox in a patient with HIV infection.
Next Document: Oral lichen planus: an update.